ZTS

What the 88% Beat Rate and -3.01% Average Drift Mean for ZTS

Across the last eight reported quarters, Zoetis (ZTS) has beaten the published earnings estimate seven times, producing an 88% beat rate and an average earnings surprise of 4.4%. That is a strong historical accuracy record. Yet the average five-day price move after those same reports is -3.01%, classified as a “down” post-earnings drift. The combination is a reminder that beating expectations and holding post-report gains are two different things.

The last four reports show exactly how that pattern plays out. On 2025-08-05, ZTS reported EPS of $1.76 against a $1.62 estimate, an 8.6% surprise, and the stock rose only 0.26% the next day and 2.5% over the following five days. On 2025-11-04, an actual EPS of $1.70 versus an estimate of $1.62, a 4.9% beat, produced a -3.19% next-day move and a -3.49% five-day move. The 2026-02-12 report, $1.48 versus $1.40, a 5.7% beat, added 0.8% the next session and 2.5% over the next five. The only miss in this sequence came on 2026-05-07, when actual EPS of $1.53 missed the $1.60 estimate, a -4.4% surprise, and the stock dropped -5.13% the next day and -13.55% over the next five sessions.

How Options-Flow Dynamics Build Into the August 6 Report

ZTS is scheduled to report before the market opens on 2026-08-06, with the current consensus EPS estimate at $1.85. As the report approaches, options markets typically reprice near-dated implied volatility, pushing straddle prices wider. Traders can compare the implied earnings move embedded in those straddles with the historical next-day range of +0.26% to -5.13% seen in the last four quarters; if the options market is pricing a larger-than-normal gap, the market's real expectation may be elevated relative to the official analyst estimate.

Beyond straddle cost, watch put/call skew and any unusual weekly options volume. Directional flow into the event can reveal whether participants are hedging long exposure or positioning for a short-term gap. From a technical view, the current price of $78.1378 sits below the 50-day EMA of $80.47, while RSI is 54.4, a neutral reading, leaving room for a post-report move in either direction depending on how the report stacks up against the $1.85 estimate.

What a Disciplined Trader Watches With This Pattern

The history for ZTS says that beating the estimate is common, but the average five-day drift of -3.01% means the post-report reward is not automatic. Two of the last three beats produced flat or negative five-day returns, and the one miss was punished with a -13.55% five-day decline. That asymmetry is what a disciplined trader has to respect.

Rather than predict the outcome, the useful exercise is to map risk. Support and resistance sit around the current $78.1378 price level and the $80.47 50-day EMA. The historical five-day extremes of +2.5% and -13.55% provide a real-world range for position sizing and stop placement. A trader can also weigh the sector context—Healthcare / Drug Manufacturers—General—where execution around guidance often matters as much as the EPS number itself.

For a deeper dive into how institutional analysts and options positioning are shaping up ahead of the August 6 report, review the full institutional verdict on ZTS.